Seizures, Epileptic

Also known as: Seizure, Epileptic / Epileptic seizure / Epileptic Seizures / Epileptic fit / Epileptic seizure (finding) / Epilepsy, unspecified, not intractable, without status epilepticus / Epilepsy, unspecified / Epilepsy and recurrent seizures / Epilepsy NOS / Seizure disorder (disorder) / Epilepsy / Epilepsy (disorder)

Drug	Drug Name	Drug Description
DB05087	Ganaxolone	A neuroactive steroid GABA-A receptor modulator used for the treatment of seizures associated with CDKL5 deficiency disorder (CDD).
DB00683	Midazolam	A short-acting benzodiazepine with rapid onset that is commonly used in seizures, anesthesia and anxiety disorders.

Drug	Drug Name	Target	Type
DB05087	Ganaxolone	GABA(A) Receptor	target
DB05087	Ganaxolone	Cytochrome P450 3A4	enzyme
DB05087	Ganaxolone	Cytochrome P450 3A5	enzyme
DB05087	Ganaxolone	Cytochrome P450 2B6	enzyme
DB05087	Ganaxolone	Cytochrome P450 2C19	enzyme
DB05087	Ganaxolone	Cytochrome P450 2D6	enzyme
DB00683	Midazolam	Cytochrome P450 3A4	enzyme
DB00683	Midazolam	Cytochrome P450 3A5	enzyme
DB00683	Midazolam	UDP-glucuronosyltransferase 1-4	enzyme
DB00683	Midazolam	Cytochrome P450 3A7	enzyme
DB00683	Midazolam	GABA(A) Receptor	target
DB00683	Midazolam	GABA(A) Receptor Benzodiazepine Binding Site	target
DB00683	Midazolam	P-glycoprotein 1	transporter
DB00683	Midazolam	Serum albumin	carrier
DB00683	Midazolam	Alpha-1-acid glycoprotein 1	carrier
DB00683	Midazolam	Adenosine receptor A2a	target
DB00683	Midazolam	Excitatory amino acid transporter 2	transporter
DB00683	Midazolam	UDP-glucuronosyltransferase 2B7	enzyme
DB00683	Midazolam	UDP-glucuronosyltransferase 2B4	enzyme

Drug	Drug Name	Phase	Status	Count
DB04864	Huperzine A	2	Recruiting	1
DB00564	Carbamazepine	3	Unknown Status	1
DB01202	Levetiracetam	3	Unknown Status	1
DB00273	Topiramate	Not Available	Completed	1